256 related articles for article (PubMed ID: 18485466)
1. GABA-A receptors and the response to CO(2) inhalation - a translational trans-species model of anxiety?
Bailey JE; Nutt DJ
Pharmacol Biochem Behav; 2008 Jul; 90(1):51-7. PubMed ID: 18485466
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.
Bailey JE; Papadopoulos A; Seddon K; Nutt DJ
J Psychopharmacol; 2009 Mar; 23(2):117-22. PubMed ID: 18562427
[TBL] [Abstract][Full Text] [Related]
3. Preliminary evidence of anxiolytic effects of the CRF(1) receptor antagonist R317573 in the 7.5% CO(2) proof-of-concept experimental model of human anxiety.
Bailey JE; Papadopoulos A; Diaper A; Phillips S; Schmidt M; van der Ark P; Dourish CT; Dawson GR; Nutt DJ
J Psychopharmacol; 2011 Sep; 25(9):1199-206. PubMed ID: 21555331
[TBL] [Abstract][Full Text] [Related]
4. GABA-benzodiazepine receptor complex and drug actions.
Saano V
Med Biol; 1987; 65(2-3):167-73. PubMed ID: 2888932
[TBL] [Abstract][Full Text] [Related]
5. The GABA-benzodiazepine receptor complex: structure, function, and role in anxiety.
Roy-Byrne PP
J Clin Psychiatry; 2005; 66 Suppl 2():14-20. PubMed ID: 15762815
[TBL] [Abstract][Full Text] [Related]
6. Effects of hippocampal injections of a novel ligand selective for the alpha 5 beta 2 gamma 2 subunits of the GABA/benzodiazepine receptor on Pavlovian conditioning.
Bailey DJ; Tetzlaff JE; Cook JM; He X; Helmstetter FJ
Neurobiol Learn Mem; 2002 Jul; 78(1):1-10. PubMed ID: 12071663
[TBL] [Abstract][Full Text] [Related]
7. Palatability-dependent appetite and benzodiazepines: new directions from the pharmacology of GABA(A) receptor subtypes.
Cooper SJ
Appetite; 2005 Apr; 44(2):133-50. PubMed ID: 15808888
[TBL] [Abstract][Full Text] [Related]
8. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
[TBL] [Abstract][Full Text] [Related]
9. 6,2'-Dihydroxyflavone, a subtype-selective partial inverse agonist of GABAA receptor benzodiazepine site.
Wang F; Xu Z; Yuen CT; Chow CY; Lui YL; Tsang SY; Xue H
Neuropharmacology; 2007 Sep; 53(4):574-82. PubMed ID: 17681556
[TBL] [Abstract][Full Text] [Related]
10. Neural and molecular mechanisms in anxiety.
Wolkowitz OM; Paul SM
Psychiatr Clin North Am; 1985 Mar; 8(1):145-58. PubMed ID: 2859577
[TBL] [Abstract][Full Text] [Related]
11. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
dos Reis LM; Canto-de-Souza A
Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
[TBL] [Abstract][Full Text] [Related]
12. New molecular targets for antianxiety interventions.
Gorman JM
J Clin Psychiatry; 2003; 64 Suppl 3():28-35. PubMed ID: 12662131
[TBL] [Abstract][Full Text] [Related]
13. [The serotoninergic mechanisms of anxiety and the action of tranquilizers (a review)].
Komissarova RA; Komissarov IV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(5):140-4. PubMed ID: 1975713
[No Abstract] [Full Text] [Related]
14. Proconflict effect of carbon dioxide inhalation in rats.
Cuccheddu T; Floris S; Serra M; Porceddu ML; Sanna E; Biggio G
Life Sci; 1995 Mar; 56(16):PL321-4. PubMed ID: 8614250
[TBL] [Abstract][Full Text] [Related]
15. [The benzodiazepine receptor: the enigma of the endogenous ligand].
Pélissolo A
Encephale; 1995; 21(2):133-40. PubMed ID: 7781584
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of the benzodiazepines: behavioral aspect.
Sepinwall J; Cook L
Fed Proc; 1980 Oct; 39(12):3024-31. PubMed ID: 7418882
[TBL] [Abstract][Full Text] [Related]
17. The role of GABA in anxiety disorders.
Lydiard RB
J Clin Psychiatry; 2003; 64 Suppl 3():21-7. PubMed ID: 12662130
[TBL] [Abstract][Full Text] [Related]
18. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
[TBL] [Abstract][Full Text] [Related]
19. [GABA and anxiety].
Guelfi JD; Waintraub L
Encephale; 1987 Jul; 13 Spec No():211-4. PubMed ID: 2891499
[No Abstract] [Full Text] [Related]
20. The role of GABA in the pathophysiology and treatment of anxiety disorders.
Nemeroff CB
Psychopharmacol Bull; 2003; 37(4):133-46. PubMed ID: 15131523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
